Both in Pharmaceuticals
Nurix Therapeutics vs Immunome
Over the past year NRIX returned +155.1% and IMNM returned +93.0%; their daily moves had a correlation of 0.45.
NRIX +155.1% IMNM +93.0%Growth of $1, one year, split-adjusted
| Metric | NRIX | IMNM |
|---|---|---|
| Price | $23.68 | $21.89 |
| Market cap | $2.46B | $2.49B |
| Today | +0.02% | +0.97% |
| 1 month | −9.7% | −20.6% |
| 6 months | +61.4% | +13.4% |
| Year to date | +24.8% | +1.9% |
| 1 year | +165.1% | +88.9% |
| Revenue growth (YoY) | −79.5% | −100.0% |
| Gross margin | 100.0% | — |
| Net margin | −990.1% | — |
| P/E (TTM) | — | — |
| Price / sales | 66.8× | — |
| Net cash | $443.5M | $520.0M |
| Dividend yield | — | — |
| Volatility (60d) | 36.6% | 50.6% |
| Short % of float | 18.3% | 16.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).